Gilead voluntarily recalls one lot of Veklury for Injection 100 mg/vial

Gilead (GILD) Sciences announced it is issuing a voluntary recall of one lot of Veklury for Injection 100 mg/vial, to the consumer level. Gilead received a customer complaint and confirmed the presence of a glass particle in the vial during the company’s investigation. The administration of an injectable product that contains glass particles may result in local irritation or swelling in response to the foreign material. The glass particulate can potentially travel, through the blood vessels, to various organs and block blood vessels in the heart, lungs or brain which can cause stroke and even lead to death. To date, Gilead has not received any reports of adverse events related to this recall. The product being recalled is the lyophilized form of Veklury for Injection 100 mg/vial packaged in single dose clear glass vials in powder form.